TY - JOUR
T1 - Secondary linitis plastica of the rectum
T2 - EUS features and tissue diagnosis (with video)
AU - Gleeson, Ferga C.
AU - Clain, Jonathan E.
AU - Rajan, Elizabeth
AU - Topazian, Mark D.
AU - Wang, Kenneth K.
AU - Wiersema, Maurits J.
AU - Zhang, Lizhi
AU - Levy, Michael J.
PY - 2008/9
Y1 - 2008/9
N2 - Background: Luminal metastases to the GI tract may be seen at the time of the primary diagnosis or may represent evidence of a distant recurrence. Objectives: To determine the prevalence of rectal-wall metastases in patients undergoing an EUS and to describe the EUS features and yield of EUS-guided FNA (EUS-FNA) and Trucut biopsy (TCB). Design: A case series. Setting: A single tertiary-referral center. Patients: Patients undergoing lower GI (LGI) EUS from July 1, 2005, to October 31, 2007. Intervention: EUS-FNA and/or TCB. Main Outcome Measurements: EUS features and cytologic and/or histologic confirmation of secondary rectal linitis plastica. Results: Over the 28-month period, an LGI-EUS was performed in 598 patients with presumed primary rectal cancer, of whom 6 (1%) were diagnosed with rectal-wall metastases. The EUS features were that of diffuse, circumferential, hypoechoic wall-thickening that mimics that of linitis plastica, breaching the muscularis propria in all cases. EUS-FNA and/or TCB of the rectal wall or perirectal lymph node established a diagnosis in all cases. The primary cancers originated from the bladder (n = 3), breast (n = 1), stomach (n = 1), and a right forearm cutaneous melanoma (n = 1). The time interval from the initial primary cancer diagnosis to that of GI-tract rectal metastasis ranged from 0 days (simultaneous diagnoses) to 119 months (mean ± SD 49 ± 43 months). Limitations: Although firm EUS criteria of rectal-wall metastases cannot be established based on 6 patients alone, certain features may prove useful for the diagnosis in the clinical practice. Conclusions: EUS-FNA and/or TCB can confirm the diagnosis of secondary linitis plastica of the rectum.
AB - Background: Luminal metastases to the GI tract may be seen at the time of the primary diagnosis or may represent evidence of a distant recurrence. Objectives: To determine the prevalence of rectal-wall metastases in patients undergoing an EUS and to describe the EUS features and yield of EUS-guided FNA (EUS-FNA) and Trucut biopsy (TCB). Design: A case series. Setting: A single tertiary-referral center. Patients: Patients undergoing lower GI (LGI) EUS from July 1, 2005, to October 31, 2007. Intervention: EUS-FNA and/or TCB. Main Outcome Measurements: EUS features and cytologic and/or histologic confirmation of secondary rectal linitis plastica. Results: Over the 28-month period, an LGI-EUS was performed in 598 patients with presumed primary rectal cancer, of whom 6 (1%) were diagnosed with rectal-wall metastases. The EUS features were that of diffuse, circumferential, hypoechoic wall-thickening that mimics that of linitis plastica, breaching the muscularis propria in all cases. EUS-FNA and/or TCB of the rectal wall or perirectal lymph node established a diagnosis in all cases. The primary cancers originated from the bladder (n = 3), breast (n = 1), stomach (n = 1), and a right forearm cutaneous melanoma (n = 1). The time interval from the initial primary cancer diagnosis to that of GI-tract rectal metastasis ranged from 0 days (simultaneous diagnoses) to 119 months (mean ± SD 49 ± 43 months). Limitations: Although firm EUS criteria of rectal-wall metastases cannot be established based on 6 patients alone, certain features may prove useful for the diagnosis in the clinical practice. Conclusions: EUS-FNA and/or TCB can confirm the diagnosis of secondary linitis plastica of the rectum.
UR - http://www.scopus.com/inward/record.url?scp=49949100753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=49949100753&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2008.04.027
DO - 10.1016/j.gie.2008.04.027
M3 - Article
C2 - 18635171
AN - SCOPUS:49949100753
SN - 0016-5107
VL - 68
SP - 591
EP - 596
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 3
ER -